Laboratorios Farmaceuticos ROVI (ROVI) — Cash Flow-to-Debt Ratio
Laboratorios Farmaceuticos ROVI (ROVI) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of €73.37 Million could theoretically repay 0% of its total liabilities (€289.27 Million) in one year. See ROVI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Laboratorios Farmaceuticos ROVI Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Laboratorios Farmaceuticos ROVI across 19 annual periods. Also explore Laboratorios Farmaceuticos ROVI equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Laboratorios Farmaceuticos ROVI (2006–2024)
Year-by-year debt coverage analysis for Laboratorios Farmaceuticos ROVI. For market capitalisation and broader financial context, see Laboratorios Farmaceuticos ROVI market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | €138.28 Million | €250.48 Million | ▲ +25.0% |
| 2023 | 0.44x | €113.25 Million | €256.39 Million | ▼ -33.6% |
| 2022 | 0.66x | €237.60 Million | €357.32 Million | ▲ +16.4% |
| 2021 | 0.57x | €149.44 Million | €261.70 Million | ▲ +144.5% |
| 2020 | 0.23x | €46.88 Million | €200.74 Million | ▲ +587.5% |
| 2019 | -0.05x | €-9.04 Million | €188.82 Million | ▼ -164.7% |
| 2018 | 0.07x | €8.53 Million | €115.23 Million | ▼ -56.2% |
| 2017 | 0.17x | €18.04 Million | €106.69 Million | ▼ -61.2% |
| 2016 | 0.44x | €45.53 Million | €104.44 Million | ▲ +46.9% |
| 2015 | 0.30x | €29.39 Million | €99.06 Million | ▲ +32.7% |
| 2014 | 0.22x | €23.00 Million | €102.85 Million | ▼ -31.4% |
| 2013 | 0.33x | €29.82 Million | €91.46 Million | ▲ +59.4% |
| 2012 | 0.20x | €19.61 Million | €95.92 Million | ▲ +83.9% |
| 2011 | 0.11x | €12.68 Million | €114.09 Million | ▼ -42.9% |
| 2010 | 0.19x | €21.19 Million | €108.75 Million | ▲ +91.2% |
| 2009 | 0.10x | €9.62 Million | €94.42 Million | ▼ -42.0% |
| 2008 | 0.18x | €12.66 Million | €72.11 Million | ▲ +818.9% |
| 2007 | 0.02x | €1.15 Million | €60.23 Million | ▼ -87.6% |
| 2006 | 0.15x | €7.72 Million | €50.23 Million | — |